Homocysteinemia and early outcome of acute ischemic stroke in elderly patients

Brain and Behavior

Volumn 6, Issue 5, 2016, Pages

  Forti, Paola ^a   Maioli, Fabiola ^b   Arnone, Giorgia ^b   Coveri, Maura ^b   Pirazzoli, Gian Luca ^a   Zoli, Marco ^a   Procaccianti, Gaetano ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b MAGGIORE HOSPITAL   (Italy)

Author keywords

Acute ischemic stroke; Over 80 years oldstroke outcome; Total homocysteine

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGE; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; BRAIN TOMOGRAPHY; CHARLSON COMORBIDITY INDEX; COMORBIDITY; DOPPLER FLOWMETRY; ELECTROCARDIOGRAPHY; FLUORESCENCE POLARIZATION IMMUNOASSAY; FUNCTIONAL STATUS; HOLTER MONITORING; HOMOCYSTINURIA; HOSPITAL ADMISSION; HUMAN; HYPERHOMOCYSTEINEMIA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORTALITY RATE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANKIN SCALE; RISK FACTOR; STROKE UNIT; TRANSTHORACIC ECHOCARDIOGRAPHY; URINALYSIS; VERY ELDERLY; BLOOD; CEREBROVASCULAR ACCIDENT; FEMALE; MALE; MORTALITY;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; OUTCOME ASSESSMENT (HEALTH CARE); STROKE;

EID: 84963865428     PISSN: None     EISSN: 21623279     Source Type: Journal    
DOI: 10.1002/brb3.460     Document Type: Article

References (34)

1. Adams, H. P., B. H. Bendixen, L. J. Kappelle, J. Biller, B. B. Love, D. L. Gordon, et al. 1993. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke J. Cereb Circ. 24:35-41.
2. American Diabetes Association. 2013. Diagnosis and classification of diabetes mellitus. Diabetes Care 36:S67-S74.
3. Bates, C. J., M. A. Mansoor, K. D. Pentieva, M. Hamer, and G. D. Mishra . 2010. Biochemical risk indices, including plasma homocysteine, that prospectively predict mortality in older British people: the National Diet and Nutrition Survey of People Aged 65 Years and Over. Br. J. Nutr. 104:893-899.
4. Brott, T., H. P. Jr Adams, C. P. Olinger, J. R. Marler, W. G. Barsan, J. Biller, et al. 1989. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20:864-870.
5. Charlson, M. E., P. Pompei, K. L. Ales, and C. R. MacKenzie . 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40:373-383.
6. Chen, R.-L., J. S. Balami, M. M. Esiri, L.-K. Chen, and A. M. Buchan . 2010. Ischemic stroke in the elderly: an overview of evidence. Nat. Rev. Neurol. 6:256-265.
7. De Ruijter, W., R. G. J. Westendorp, W. J. J. Assendelft, W. P. J. den Elzen, A. J. M. de Craen, S. le Cessie, et al. 2009. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ 338:a3083.
8. Fonarow, G. C., J. L. Saver, E. E. Smith, J. P. Broderick, D. O. Kleindorfer, R. L. Sacco, et al. 2012. Relationship of national institutes of health stroke scale to 30-day mortality in medicare beneficiaries with acute ischemic stroke. J. Am. Heart Assoc. 1:42-50.
9. Forti, P., F. Maioli, G. Procaccianti, V. Nativio, M.-V. Lega, M. Coveri, et al. 2013. Independent predictors of ischemic stroke in the elderly: prospective data from a stroke unit. Neurology 80:29-38.
10. Froissart, M., J. Rossert, C. Jacquot, M. Paillard, and P. Houillier . 2005. Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J. Am. Soc. Nephrol. 16:763-773.
11. Grundy, S. M., J. I. Cleeman, C. N. B. Merz, H. B. Brewer, L. T. Clark, D. B. Hunninghake, et al. 2004. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110:227-239.
12. Haapaniemi, E., J. Helenius, L. Soinne, M. Syrjälä, M. Kaste, and T. Tatlisumak . 2007. Serial measurements of plasma homocysteine levels in early and late phases of ischemic stroke. Eur. J. Neurol. 14:12-17.
13. Hatano, S. 1976. Experience from a multicentre stroke register: a preliminary report. Bull. World Health Organ. 54:541-553.
14. Kalani, A., P. K. Kamat, S. C. Tyagi, and N. Tyagi . 2013. Synergy of homocysteine, microRNA, and epigenetics: a novel therapeutic approach for stroke. Mol. Neurobiol. 48:157-168.
15. Koennecke, H.-C., W. Belz, D. Berfelde, M. Endres, S. Fitzek, F. Hamilton, et al. 2011. Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unit. Neurology 77:965-972.
16. Kwon, H.-M., Y.-S. Lee, H.-J. Bae, and D.-W. Kang . 2014. Homocysteine as a predictor of early neurological deterioration in acute ischemic stroke. Stroke 45:871-873.
17. Manolescu, B. N., E. Oprea, I. C. Farcasanu, M. Berteanu, and C. Cercasov . 2010. Homocysteine and vitamin therapy in stroke prevention and treatment: a review. Acta Biochim. Pol. 57:467-477.
18. Medina, M., J. L. Urdiales, and M. I. Amores-Sánchez . 2001. Roles of homocysteine in cell metabolism: old and new functions. Eur. J. Biochem. 268:3871-3882.
19. Okubadejo, N. U., O. O. Oladipo, A. A. Adeyomoye, G. O. Awosanya, and M. A. Danesi . 2008. Exploratory study of plasma total homocysteine and its relationship to short-term outcome in acute ischaemic stroke in Nigerians. BMC Neurol. 8:26.
20. Perini, F., E. Galloni, I. Bolgan, G. Bader, R. Ruffini, E. Arzenton, et al. 2005. Elevated plasma homocysteine in acute stroke was not associated with severity and outcome: stronger association with small artery disease. Neurol. Sci. 26:310-318.
21. Pniewski, J., M. Chodakowska-Zebrowska, R. Woźniak, K. Stepień, and A. Stafiej . 2003. Plasma homocysteine level and the course of ischemic stroke. Acta Neurobiol. Exp. 63:127-130.
22. Saberi, A., M. J. Saber, S. A. Roudbary, and A. Shirzani . 2014. Serum homocysteine and the short-term outcome of ischemic stroke. J. Neurol. Res. 4:15-21.
23. Schalinske, K. L., and A. L. Smazal . 2012. Homocysteine imbalance: a pathological metabolic marker. Adv. Nutr. 3:755-762.
24. Silver, F. L., J. W. Norris, A. J. Lewis, and V. C. Hachinski . 1984. Early mortality following stroke: a prospective review. Stroke 15:492-496.
25. Song, I.-U., Y.-D. Kim, J.-S. Kim, K.-S. Lee, and S.-W. Chung . 2010. Can high-sensitivity C-reactive protein and plasma homocysteine levels independently predict the prognosis of patients with functional disability after first-ever ischemic stroke? Eur. Neurol. 64:304-310.
26. Tu, W.-J., S.-J. Zhao, T.-G. Liu, D.-G. Yang, and H. Chen . 2013. Combination of high-sensitivity C-reactive protein and homocysteine predicts the short-term outcomes of Chinese patients with acute ischemic stroke. Neurol. Res. 35:912-921.
27. Van Swieten, J. C., P. J. Koudstaal, M. C. Visser, H. J. Schouten, and J. van Gijn . 1988. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604-607.
28. Vollset, S. E., H. Refsum, A. Tverdal, O. Nygård, J. E. Nordrehaug, G. S. Tell, et al. 2001. Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study. Am. J. Clin. Nutr. 74:130-136.
29. Weisscher, N., M. Vermeulen, Y. B. Roos, and R. J. de Haan . 2008. What should be defined as good outcome in stroke trials; a modified Rankin score of 0-1 or 0-2? J. Neurol. 255:867-874.
30. Wiseman, S., F. Marlborough, F. Doubal, D. J. Webb, and J. Wardlaw . 2014. Blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-lacunar stroke and non-stroke: systematic review and meta-analysis. Cerebrovasc. Dis. 37:64-75.
31. Wu, X.-Q., J. Ding, A.-Y. Ge, F.-F. Liu, X. Wang, and W. Fan . 2013. Acute phase homocysteine related to severity and outcome of atherothrombotic stroke. Eur. J. Intern. Med. 24:362-367.
32. Wu, D., L. Wang, W. Teng, K. Huang, and X. Shang . 2015. Correlation of post-stroke fatigue with glucose, homocysteine and functional disability. Acta Neurol. Scand. 131:400-404.
33. Yoldas, T., M. Gonen, A. Godekmerdan, F. Ilhan, and E. Bayram . 2007. The serum high-sensitive C reactive protein and homocysteine levels to evaluate the prognosis of acute ischemic stroke. Mediators Inflamm. 2007:15929.
34. Zhong, C., L. Lv, C. Liu, L. Zhao, M. Zhou, W. Sun, et al. 2014. High homocysteine and blood pressure related to poor outcome of acute ischemia stroke in chinese population. PLoS One 9:e107498.